Ping An Biomedical Statistics
Ping An Biomedical (PASW) Stock Statistics & Valuation Metrics
Total Valuation
Ping An Biomedical has a market cap or net worth of $3.99M. The enterprise value is $9.30T.
- Market Cap
- $3.99M
- Enterprise Value
- $9.30T
Share Statistics
Ping An Biomedical has 2,821,675 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,821,675
- Owned by Insiders
- ―
- Owned by Institutions
- 0.20%
Financial Efficiency
Ping An Biomedical’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -23.05%.
- Return on Equity (ROE)
- -0.28
- Return on Assets (ROA)
- -0.19
- Return on Invested Capital (ROIC)
- -23.05%
- Return on Capital Employed (ROCE)
- -0.32
- Revenue Per Employee
- 4.88M
- Profits Per Employee
- -1.83M
- Employee Count
- 7
- Asset Turnover
- 0.50
- Inventory Turnover
- 75.13
Valuation Ratios
The current PE Ratio of Ping An Biomedical is -0.63. Ping An Biomedical’s PEG ratio is 0.01.
- PE Ratio
- -0.63
- PS Ratio
- 1.02
- PB Ratio
- 0.15
- Price to FCF
- -4.68
- Price to Operating Cash Flow
- -2.10
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Ping An Biomedical had revenue of 34.15M and earned -12.83M in profits. Earnings per share was -27.60.
- Revenue
- 34.15M
- Gross Profit
- 949.50K
- Operating Income
- -14.70M
- Pretax Income
- -14.68M
- Net Income
- -12.83M
- EBITDA
- -14.37M
- Earnings Per Share (EPS)
- -27.60
Cash Flow
In the last 12 months, operating cash flow was -5.54M and capital expenditures 0, giving a free cash flow of -5.54M billion.
- Operating Cash Flow
- -5.54M
- Free Cash Flow
- -5.54M
- Free Cash Flow per Share
- -4.39
Dividends & Yields
Ping An Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -20.83%
- Earnings Yield
- -31.66%
Stock Price Statistics
- Beta
- 1.74
- 52-Week Price Change
- -93.98%
- 50-Day Moving Average
- 4.49
- 200-Day Moving Average
- 5.75
- Relative Strength Index (RSI)
- 31.09
- Average Volume (3m)
- 185.84K
Financial Position
Ping An Biomedical as a current ratio of 2.76, with Debt / Equity ratio of 23.14%
- Current Ratio
- 2.76
- Quick Ratio
- 2.74
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- -0.65
- Interest Coverage Ratio
- -47.88
Taxes
In the past 12 months, Ping An Biomedical has paid -1.86M in taxes.
- Income Tax
- -1.86M
- Effective Tax Rate
- 0.13
Enterprise Valuation
Ping An Biomedical EV to EBITDA ratio is -2.85, with an EV/FCF ratio of -5.42.
- EV to Sales
- 1.18
- EV to EBITDA
- -2.85
- EV to Free Cash Flow
- -5.42
- EV to Operating Cash Flow
- -5.42
Balance Sheet
Ping An Biomedical has $6.84M in cash and marketable securities with $10.27M in debt, giving a net cash position of -$3.43M billion.
- Cash & Marketable Securities
- $6.84M
- Total Debt
- $10.27M
- Net Cash
- -$3.43M
- Net Cash Per Share
- -$1.22
- Tangible Book Value Per Share
- $61.90
Margins
Gross margin is 9.27%, with operating margin of -41.34%, and net profit margin of -14.78%.
- Gross Margin
- 9.27%
- Operating Margin
- -41.34%
- Pretax Margin
- -18.28%
- Net Profit Margin
- -14.78%
- EBITDA Margin
- -41.32%
- EBIT Margin
- -41.34%
Analyst Forecast
The average price target for Ping An Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―

